Invention Grant
- Patent Title: Formulation of a peptide vaccine
-
Application No.: US16311629Application Date: 2017-06-19
-
Publication No.: US10702598B2Publication Date: 2020-07-07
- Inventor: Gwenn Eveline Mulder
- Applicant: ISA PHARMACEUTICALS B.V.
- Applicant Address: NL Leiden
- Assignee: ISA PHARMACEUTICALS B.V.
- Current Assignee: ISA PHARMACEUTICALS B.V.
- Current Assignee Address: NL Leiden
- Agency: Foley & Lardner LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6987d605
- International Application: PCT/EP2017/064882 WO 20170619
- International Announcement: WO2017/220463 WO 20171228
- Main IPC: A61K47/00
- IPC: A61K47/00 ; A61K38/00 ; A61K38/02 ; A61K39/12 ; A61K39/00 ; A61K47/10 ; A61P35/00 ; A61K9/107 ; A61K47/12 ; A61K47/14 ; A61K9/00
Abstract:
The invention relates to a novel reconstitution composition, a pharmaceutical composition and kit of parts comprising said reconstitution composition. The invention further relates to a method of treatment using said pharmaceutical composition and/or the pharmaceutical composition for use as a medicament. Also provided is a method for reconstituting dried peptides and a method for preparing a pharmaceutical composition using the reconstitution composition of the invention.
Public/Granted literature
- US20190231863A1 FORMULATION OF A PEPTIDE VACCINE Public/Granted day:2019-08-01
Information query
